Type	Name	Date
Indenture	Indenture, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee	08/23/2021
Indenture	First Supplemental Indenture, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee and as collateral agent	08/23/2021
Indenture	Second Supplemental Indenture, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (including the form of 2.00% Convertible Senior Note due 2026)	05/14/2019